 Stephanie Dillon
Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 27 | 2025 | 2719 | 3.380 |
Why?
| | Intestinal Mucosa | 12 | 2021 | 589 | 2.930 |
Why?
| | Gastrointestinal Microbiome | 14 | 2025 | 640 | 2.860 |
Why?
| | HIV-1 | 19 | 2024 | 836 | 2.530 |
Why?
| | Dysbiosis | 9 | 2022 | 169 | 2.400 |
Why?
| | CD4-Positive T-Lymphocytes | 14 | 2022 | 1056 | 1.960 |
Why?
| | Dendritic Cells | 16 | 2020 | 479 | 1.840 |
Why?
| | Immunity, Mucosal | 5 | 2017 | 94 | 1.550 |
Why?
| | Colon | 8 | 2024 | 252 | 1.420 |
Why?
| | Gastrointestinal Tract | 5 | 2022 | 185 | 1.340 |
Why?
| | Microbiota | 5 | 2023 | 728 | 1.180 |
Why?
| | Lymphocyte Activation | 8 | 2017 | 1109 | 1.160 |
Why?
| | Bacterial Translocation | 4 | 2019 | 40 | 1.130 |
Why?
| | Interferon-gamma | 10 | 2019 | 772 | 0.910 |
Why?
| | Th1 Cells | 3 | 2019 | 137 | 0.750 |
Why?
| | Butyrates | 2 | 2021 | 57 | 0.690 |
Why?
| | Immunity, Innate | 4 | 2021 | 803 | 0.630 |
Why?
| | Th17 Cells | 1 | 2019 | 83 | 0.620 |
Why?
| | Escherichia coli | 5 | 2014 | 766 | 0.610 |
Why?
| | Salmonella typhimurium | 3 | 2021 | 174 | 0.590 |
Why?
| | Interferon Type I | 1 | 2018 | 139 | 0.560 |
Why?
| | Granzymes | 3 | 2022 | 47 | 0.530 |
Why?
| | Immunologic Factors | 1 | 2018 | 230 | 0.510 |
Why?
| | Bacteria | 3 | 2025 | 813 | 0.500 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 427 | 0.480 |
Why?
| | Mucous Membrane | 2 | 2015 | 122 | 0.480 |
Why?
| | Escherichia coli Infections | 2 | 2013 | 112 | 0.470 |
Why?
| | Interleukin-23 | 2 | 2013 | 19 | 0.450 |
Why?
| | Lymphocytes | 3 | 2021 | 378 | 0.450 |
Why?
| | Aging | 2 | 2025 | 1774 | 0.440 |
Why?
| | Lymphocyte Subsets | 1 | 2014 | 84 | 0.430 |
Why?
| | T-Lymphocytes | 5 | 2021 | 1933 | 0.430 |
Why?
| | Endotoxemia | 1 | 2014 | 86 | 0.410 |
Why?
| | Immunity | 1 | 2014 | 138 | 0.410 |
Why?
| | Flow Cytometry | 9 | 2017 | 1155 | 0.400 |
Why?
| | Inflammation | 5 | 2021 | 2737 | 0.400 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2015 | 857 | 0.390 |
Why?
| | Immune Tolerance | 3 | 2014 | 355 | 0.380 |
Why?
| | Toll-Like Receptor 8 | 1 | 2010 | 6 | 0.340 |
Why?
| | Middle Aged | 21 | 2025 | 31090 | 0.340 |
Why?
| | Toll-Like Receptor 7 | 1 | 2010 | 38 | 0.340 |
Why?
| | Humans | 44 | 2025 | 129266 | 0.330 |
Why?
| | Adult | 23 | 2025 | 35495 | 0.330 |
Why?
| | Viremia | 1 | 2010 | 131 | 0.330 |
Why?
| | Caspase 3 | 1 | 2010 | 245 | 0.320 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 232 | 0.320 |
Why?
| | Myeloid Cells | 1 | 2010 | 141 | 0.320 |
Why?
| | Ruminococcus | 2 | 2021 | 9 | 0.310 |
Why?
| | Viral Load | 5 | 2015 | 448 | 0.310 |
Why?
| | Membrane Glycoproteins | 3 | 2015 | 476 | 0.300 |
Why?
| | Interleukin-17 | 3 | 2023 | 108 | 0.300 |
Why?
| | Young Adult | 11 | 2020 | 12391 | 0.300 |
Why?
| | Toll-Like Receptor 2 | 2 | 2006 | 113 | 0.300 |
Why?
| | Lymphoid Tissue | 1 | 2008 | 67 | 0.290 |
Why?
| | Oncogene Proteins, Viral | 1 | 2007 | 22 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2006 | 175 | 0.270 |
Why?
| | Interferon-alpha | 2 | 2020 | 194 | 0.270 |
Why?
| | Human papillomavirus 16 | 1 | 2007 | 34 | 0.270 |
Why?
| | Leukocytes, Mononuclear | 5 | 2024 | 545 | 0.260 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2007 | 42 | 0.260 |
Why?
| | Zymosan | 1 | 2006 | 65 | 0.260 |
Why?
| | Cross-Sectional Studies | 4 | 2018 | 5050 | 0.260 |
Why?
| | Th2 Cells | 2 | 2004 | 171 | 0.250 |
Why?
| | Papillomavirus Infections | 2 | 2007 | 297 | 0.250 |
Why?
| | Antiviral Agents | 3 | 2020 | 712 | 0.250 |
Why?
| | Antigen-Presenting Cells | 1 | 2006 | 151 | 0.250 |
Why?
| | Apoptosis | 2 | 2014 | 2499 | 0.240 |
Why?
| | Immunoglobulin A | 2 | 2022 | 200 | 0.240 |
Why?
| | Virus Replication | 3 | 2015 | 450 | 0.240 |
Why?
| | Interleukin-10 | 6 | 2013 | 300 | 0.240 |
Why?
| | Cells, Cultured | 7 | 2021 | 4077 | 0.230 |
Why?
| | Healthy Aging | 1 | 2025 | 34 | 0.230 |
Why?
| | Receptors, Cell Surface | 2 | 2021 | 380 | 0.230 |
Why?
| | Biopsy | 3 | 2018 | 1092 | 0.220 |
Why?
| | Male | 22 | 2025 | 63512 | 0.220 |
Why?
| | Endogenous Retroviruses | 1 | 2024 | 34 | 0.210 |
Why?
| | Receptors, IgG | 2 | 2014 | 73 | 0.210 |
Why?
| | Enterobacteriaceae | 2 | 2017 | 39 | 0.210 |
Why?
| | Antigens, CD1 | 2 | 2015 | 58 | 0.200 |
Why?
| | Female | 21 | 2025 | 68551 | 0.200 |
Why?
| | Aged | 10 | 2025 | 22032 | 0.200 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 311 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.200 |
Why?
| | Arthritis, Experimental | 1 | 2023 | 135 | 0.190 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 569 | 0.190 |
Why?
| | MAP Kinase Signaling System | 1 | 2004 | 313 | 0.190 |
Why?
| | Feces | 3 | 2025 | 441 | 0.190 |
Why?
| | Phenotype | 4 | 2019 | 3074 | 0.190 |
Why?
| | Interleukin-2 | 2 | 2022 | 437 | 0.190 |
Why?
| | Acinetobacter | 1 | 2021 | 13 | 0.180 |
Why?
| | Interleukin-15 | 1 | 2021 | 82 | 0.180 |
Why?
| | Antigens, CD | 3 | 2015 | 489 | 0.180 |
Why?
| | Glycoproteins | 2 | 2015 | 338 | 0.180 |
Why?
| | Gene Expression Profiling | 4 | 2024 | 1688 | 0.170 |
Why?
| | Interferon-beta | 1 | 2020 | 89 | 0.170 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7055 | 0.170 |
Why?
| | DNA-Binding Proteins | 2 | 2007 | 1446 | 0.170 |
Why?
| | Bacteria, Anaerobic | 1 | 2020 | 22 | 0.170 |
Why?
| | Interleukin-12 | 5 | 2012 | 118 | 0.170 |
Why?
| | Monocytes | 2 | 2013 | 551 | 0.170 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2025 | 521 | 0.160 |
Why?
| | Adaptive Immunity | 1 | 2021 | 161 | 0.160 |
Why?
| | Membrane Proteins | 1 | 2006 | 1117 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 209 | 0.160 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2019 | 83 | 0.160 |
Why?
| | Gram-Positive Bacteria | 1 | 2019 | 44 | 0.150 |
Why?
| | Gram-Negative Bacteria | 1 | 2019 | 70 | 0.150 |
Why?
| | CD4 Lymphocyte Count | 3 | 2014 | 266 | 0.150 |
Why?
| | Diet, High-Fat | 1 | 2019 | 239 | 0.150 |
Why?
| | Antigen Presentation | 1 | 1998 | 207 | 0.140 |
Why?
| | Interleukins | 1 | 2019 | 241 | 0.140 |
Why?
| | Immunoglobulins | 2 | 2015 | 160 | 0.140 |
Why?
| | CD40 Antigens | 2 | 2015 | 88 | 0.140 |
Why?
| | Body Composition | 1 | 2021 | 649 | 0.140 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2021 | 207 | 0.140 |
Why?
| | GPI-Linked Proteins | 2 | 2014 | 68 | 0.140 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 83 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2020 | 3377 | 0.130 |
Why?
| | Age Factors | 3 | 2019 | 3140 | 0.130 |
Why?
| | Cell Proliferation | 5 | 2021 | 2375 | 0.130 |
Why?
| | DNA, Bacterial | 1 | 2017 | 321 | 0.120 |
Why?
| | Cluster Analysis | 1 | 2017 | 479 | 0.120 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.120 |
Why?
| | Tuberculosis | 1 | 1998 | 273 | 0.120 |
Why?
| | Colitis | 1 | 2017 | 241 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 1097 | 0.120 |
Why?
| | Immunophenotyping | 2 | 2014 | 310 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 151 | 0.110 |
Why?
| | Receptors, Peptide | 1 | 2014 | 17 | 0.110 |
Why?
| | CD56 Antigen | 1 | 2014 | 36 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2014 | 27 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 776 | 0.110 |
Why?
| | Intestines | 1 | 2017 | 347 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 2 | 2014 | 412 | 0.110 |
Why?
| | Cell Lineage | 1 | 2015 | 332 | 0.100 |
Why?
| | Homeostasis | 1 | 2017 | 605 | 0.100 |
Why?
| | Spleen | 2 | 2006 | 506 | 0.100 |
Why?
| | Phylogeny | 1 | 2017 | 849 | 0.100 |
Why?
| | Cell Separation | 2 | 2014 | 316 | 0.100 |
Why?
| | Lipoproteins | 2 | 2004 | 171 | 0.100 |
Why?
| | Pilot Projects | 1 | 2017 | 1584 | 0.100 |
Why?
| | Bacteroides fragilis | 1 | 2012 | 13 | 0.100 |
Why?
| | Fetal Tissue Transplantation | 2 | 2003 | 31 | 0.100 |
Why?
| | Enterococcus | 1 | 2012 | 22 | 0.100 |
Why?
| | Cytokines | 3 | 2010 | 2013 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 131 | 0.090 |
Why?
| | Lipopolysaccharides | 2 | 2006 | 877 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2024 | 2537 | 0.090 |
Why?
| | Genes, bcl-2 | 1 | 2010 | 21 | 0.090 |
Why?
| | Diet | 2 | 2019 | 1212 | 0.090 |
Why?
| | Biodiversity | 1 | 2014 | 377 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2006 | 2871 | 0.080 |
Why?
| | Signal Transduction | 4 | 2021 | 4926 | 0.080 |
Why?
| | Mice, Transgenic | 2 | 2006 | 2117 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2006 | 5439 | 0.080 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 45 | 0.080 |
Why?
| | Mice | 7 | 2023 | 16915 | 0.080 |
Why?
| | Chemotaxis | 1 | 2009 | 129 | 0.070 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 263 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2019 | 372 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.070 |
Why?
| | Hepatitis C, Chronic | 1 | 2009 | 153 | 0.070 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2007 | 186 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 182 | 0.070 |
Why?
| | Parkinson Disease | 2 | 2003 | 461 | 0.060 |
Why?
| | Capsid Proteins | 1 | 2007 | 90 | 0.060 |
Why?
| | HIV | 1 | 2007 | 226 | 0.060 |
Why?
| | Animals | 8 | 2023 | 35309 | 0.060 |
Why?
| | Yeasts | 1 | 2006 | 52 | 0.060 |
Why?
| | Lectins, C-Type | 1 | 2006 | 71 | 0.060 |
Why?
| | Ligands | 2 | 2007 | 621 | 0.060 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2006 | 57 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2012 | 1202 | 0.060 |
Why?
| | Adolescent | 2 | 2019 | 20313 | 0.060 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2007 | 200 | 0.060 |
Why?
| | Body Mass Index | 1 | 2014 | 2272 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 1 | 2006 | 376 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 169 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 20 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2146 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2004 | 90 | 0.060 |
Why?
| | Vaccines, DNA | 1 | 2004 | 28 | 0.060 |
Why?
| | CD11c Antigen | 1 | 2004 | 41 | 0.060 |
Why?
| | CD11b Antigen | 1 | 2004 | 60 | 0.060 |
Why?
| | Dipeptides | 1 | 2004 | 47 | 0.060 |
Why?
| | Antigens, Differentiation | 1 | 2004 | 81 | 0.060 |
Why?
| | Retroelements | 1 | 2024 | 44 | 0.050 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2024 | 30 | 0.050 |
Why?
| | Ovalbumin | 1 | 2004 | 178 | 0.050 |
Why?
| | Papillomaviridae | 1 | 2004 | 114 | 0.050 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2004 | 96 | 0.050 |
Why?
| | Transforming Growth Factor beta | 1 | 2006 | 455 | 0.050 |
Why?
| | Neurons | 2 | 2003 | 1494 | 0.050 |
Why?
| | Anti-Allergic Agents | 1 | 2003 | 45 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 184 | 0.050 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 179 | 0.050 |
Why?
| | Dopamine | 2 | 2003 | 287 | 0.050 |
Why?
| | Protein Subunits | 1 | 2004 | 234 | 0.050 |
Why?
| | Viral Vaccines | 1 | 2004 | 94 | 0.050 |
Why?
| | Antibodies, Viral | 1 | 2007 | 601 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 216 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2007 | 848 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2010 | 1887 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 178 | 0.050 |
Why?
| | Frailty | 1 | 2025 | 153 | 0.050 |
Why?
| | Time Factors | 2 | 2006 | 6543 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 720 | 0.050 |
Why?
| | Immunoglobulin E | 1 | 2003 | 329 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.050 |
Why?
| | Propionates | 1 | 2021 | 37 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 433 | 0.050 |
Why?
| | Control Groups | 1 | 2001 | 11 | 0.050 |
Why?
| | Brain Tissue Transplantation | 1 | 2001 | 15 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 399 | 0.050 |
Why?
| | Eosinophilia | 1 | 2003 | 204 | 0.040 |
Why?
| | Mesencephalon | 1 | 2001 | 66 | 0.040 |
Why?
| | Papillomavirus Vaccines | 1 | 2004 | 232 | 0.040 |
Why?
| | Acetates | 1 | 2021 | 100 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 244 | 0.040 |
Why?
| | Interleukin-12 Subunit p35 | 1 | 2019 | 3 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1247 | 0.040 |
Why?
| | Phosphorylation | 1 | 2004 | 1710 | 0.040 |
Why?
| | Immunologic Memory | 2 | 2014 | 349 | 0.040 |
Why?
| | Tight Junctions | 1 | 2019 | 75 | 0.040 |
Why?
| | Tuberculin | 1 | 1998 | 8 | 0.040 |
Why?
| | Freund's Adjuvant | 1 | 1998 | 19 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1722 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2019 | 57 | 0.040 |
Why?
| | Macrophages | 1 | 2006 | 1484 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2019 | 237 | 0.040 |
Why?
| | Metagenome | 1 | 2019 | 140 | 0.040 |
Why?
| | Up-Regulation | 2 | 2014 | 839 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2276 | 0.040 |
Why?
| | Metagenomics | 1 | 2019 | 155 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 704 | 0.030 |
Why?
| | Epitopes | 1 | 1998 | 470 | 0.030 |
Why?
| | Histones | 1 | 2021 | 588 | 0.030 |
Why?
| | Disease Progression | 2 | 2019 | 2630 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 590 | 0.030 |
Why?
| | Virion | 1 | 2015 | 82 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5409 | 0.030 |
Why?
| | Computational Biology | 1 | 2019 | 595 | 0.030 |
Why?
| | Caspase 1 | 1 | 2014 | 143 | 0.030 |
Why?
| | Antigens, CD19 | 1 | 2014 | 114 | 0.030 |
Why?
| | Biomarkers | 2 | 2019 | 3968 | 0.030 |
Why?
| | Tomography, Emission-Computed | 2 | 2003 | 66 | 0.020 |
Why?
| | Chronic Disease | 2 | 2009 | 1716 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1085 | 0.020 |
Why?
| | Blood | 1 | 2012 | 105 | 0.020 |
Why?
| | Liver | 1 | 2019 | 1839 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 874 | 0.020 |
Why?
| | Cell Survival | 1 | 2014 | 1075 | 0.020 |
Why?
| | Chloroquine | 1 | 2009 | 51 | 0.020 |
Why?
| | Reference Standards | 1 | 2009 | 176 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 33 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2003 | 0.020 |
Why?
| | Double-Blind Method | 2 | 2003 | 1875 | 0.020 |
Why?
| | Gene Products, gag | 1 | 2007 | 36 | 0.020 |
Why?
| | Anti-Infective Agents | 1 | 2009 | 248 | 0.020 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2007 | 232 | 0.020 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 195 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2007 | 470 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2004 | 77 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1835 | 0.010 |
Why?
| | Schistosoma mansoni | 1 | 2003 | 37 | 0.010 |
Why?
| | Putamen | 1 | 2003 | 22 | 0.010 |
Why?
| | Antiparkinson Agents | 1 | 2003 | 28 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2004 | 265 | 0.010 |
Why?
| | Antigens, Viral | 1 | 2004 | 178 | 0.010 |
Why?
| | Craniotomy | 1 | 2003 | 67 | 0.010 |
Why?
| | Treatment Failure | 1 | 2003 | 339 | 0.010 |
Why?
| | Models, Animal | 1 | 2004 | 376 | 0.010 |
Why?
| | Viral Proteins | 1 | 2004 | 327 | 0.010 |
Why?
| | Dihydroxyphenylalanine | 1 | 2001 | 9 | 0.010 |
Why?
| | Fluorine Radioisotopes | 1 | 2001 | 11 | 0.010 |
Why?
| | Culture Techniques | 1 | 2001 | 81 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 385 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2003 | 1199 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2003 | 1014 | 0.010 |
Why?
| | Cell Line | 1 | 2004 | 2779 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2004 | 3080 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 10202 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2001 | 2740 | 0.010 |
Why?
| | Brain | 1 | 2001 | 2669 | 0.000 |
Why?
|
|
Dillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|